ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      83.025
      -0.12%
      Bitcoin
      63,950.66
      -0.08%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Voyager Therapeutics Inc (VYGR)

      7. Voyager Therapeutics Inc (VYGR) News

      VYGR

      Voyager Therapeutics (VYGR)

      Voyager Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VYGR
      DateTimeSourceHeadlineSymbolCompany
      04/22/20244:30PMGlobeNewswire Inc.Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual MeetingNASDAQ:VYGRVoyager Therapeutics Inc
      04/16/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone PaymentNASDAQ:VYGRVoyager Therapeutics Inc
      03/26/20244:01PMGlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
      03/13/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical OfficerNASDAQ:VYGRVoyager Therapeutics Inc
      02/28/20244:01PMGlobeNewswire Inc.Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
      02/28/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
      02/26/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone PaymentNASDAQ:VYGRVoyager Therapeutics Inc
      02/22/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      02/22/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      02/21/20243:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      02/21/20243:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      02/21/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
      02/20/20243:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      02/20/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late ResearchNASDAQ:VYGRVoyager Therapeutics Inc
      02/16/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      02/16/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      02/16/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      02/07/20247:00AMGlobeNewswire Inc.Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences ConferenceNASDAQ:VYGRVoyager Therapeutics Inc
      01/19/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      01/19/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      01/17/20244:20PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VYGRVoyager Therapeutics Inc
      01/17/20243:33PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      01/17/20243:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
      01/08/20244:49PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
      01/08/20244:04PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VYGRVoyager Therapeutics Inc
      01/04/202410:45PMGlobeNewswire Inc.Voyager Therapeutics Announces Pricing of Public OfferingNASDAQ:VYGRVoyager Therapeutics Inc
      01/04/20245:20PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VYGRVoyager Therapeutics Inc
      01/04/20244:14PMGlobeNewswire Inc.Voyager Therapeutics Announces Proposed Public OfferingNASDAQ:VYGRVoyager Therapeutics Inc
      01/03/20247:00AMGlobeNewswire Inc.Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:VYGRVoyager Therapeutics Inc
      01/02/20247:46AMDow Jones NewsVoyager Therapeutics Shares Leap Premarket on Novartis CollaborationNASDAQ:VYGRVoyager Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:VYGR